Lexology May 23, 2024
BakerHostetler

A recently announced settlement with online alcohol addiction treatment service Monument Inc. demonstrates the Federal Trade Commission’s (FTC) continued focus on the use and disclosure of health data. The proposed settlement follows a string of FTC enforcement actions in this space, including those involving health companies GoodRx and BetterHelp. If approved, the stipulated order would prohibit Monument from disclosing users’ health information for many advertising purposes.

The complaint alleges violations of the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018 (OARFPA), which permits the FTC to seek civil penalties for unfair or deceptive acts or practices with respect to any substance use disorder treatment service or substance use disorder treatment product.

While many of the remedies...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, Health IT, Healthcare System, HIPAA, Patient / Consumer, Privacy / Security, Provider, Technology
FTC chief flags data privacy concerns in 23andMe bankruptcy
23andMe is potentially selling more than just genetic data. Survey info is just as much a privacy problem
23andMe Bankruptcy Court Could Appoint A Privacy Ombudsman. Will It?
A Privacy-Preserving On-Device Design For Wearable AI
Ranked: Which AI Chatbots Collect the Most Data About You?

Share This Article